A detailed history of Laurel Wealth Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 45,210 shares of ABT stock, worth $5.32 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
45,210
Previous 45,471 0.57%
Holding current value
$5.32 Million
Previous $5.18 Million 1.37%
% of portfolio
0.82%
Previous 0.84%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$111.93 - $119.39 $29,213 - $31,160
-261 Reduced 0.57%
45,210 $5.11 Million
Q3 2024

Nov 05, 2024

SELL
$100.07 - $118.13 $134,093 - $158,294
-1,340 Reduced 2.86%
45,471 $5.18 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $303,197 - $338,444
3,010 Added 6.87%
46,811 $4.86 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $36,470 - $40,279
333 Added 0.77%
43,801 $4.98 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $218,259 - $267,168
-2,420 Reduced 5.27%
43,468 $4.78 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $188,194 - $225,801
-1,970 Reduced 4.12%
45,888 $4.44 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $44,645 - $49,744
-443 Reduced 0.92%
47,858 $5.22 Million
Q1 2023

May 08, 2023

BUY
$96.86 - $114.01 $113,616 - $133,733
1,173 Added 2.49%
48,301 $4.89 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $151,620 - $177,874
1,595 Added 3.5%
47,128 $5.18 Million
Q3 2022

Nov 15, 2022

BUY
$96.76 - $112.03 $155,977 - $180,592
1,612 Added 3.67%
45,533 $4.41 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $32,662 - $39,478
320 Added 0.73%
43,921 $4.77 Million
Q1 2022

May 02, 2022

SELL
$114.02 - $139.04 $41,503 - $50,610
-364 Reduced 0.83%
43,601 $5.16 Million
Q4 2021

Feb 01, 2022

BUY
$115.53 - $141.46 $36,507 - $44,701
316 Added 0.72%
43,965 $6.19 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $76,295 - $84,405
-654 Reduced 1.48%
43,649 $5.16 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $39,248 - $46,200
371 Added 0.84%
44,303 $5.14 Million
Q1 2021

May 04, 2021

SELL
$108.84 - $128.23 $20,570 - $24,235
-189 Reduced 0.43%
43,932 $5.27 Million
Q4 2020

Feb 04, 2021

BUY
$105.0 - $114.42 $178,500 - $194,514
1,700 Added 4.01%
44,121 $4.83 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $35,739 - $43,403
390 Added 0.93%
42,421 $4.62 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $56,508 - $72,324
738 Added 1.79%
42,031 $3.84 Million
Q1 2020

Apr 30, 2020

BUY
$62.82 - $91.86 $161,133 - $235,620
2,565 Added 6.62%
41,293 $3.26 Million
Q4 2019

Jan 31, 2020

SELL
$78.51 - $87.4 $33,759 - $37,582
-430 Reduced 1.1%
38,728 $3.36 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $26,188 - $28,396
-320 Reduced 0.81%
39,158 $3.28 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $36,658 - $42,755
-503 Reduced 1.26%
39,478 $3.32 Million
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $24,501 - $29,622
370 Added 0.93%
39,981 $3.2 Million
Q4 2018

Feb 08, 2019

BUY
$65.56 - $74.27 $2.6 Million - $2.94 Million
39,611 New
39,611 $2.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Laurel Wealth Advisors LLC Portfolio

Follow Laurel Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors LLC with notifications on news.